NASDAQ
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Open
$10.76
Previous Close
$10.67
Day High
$10.78
Day Low
$10.15
52 Week High
$31.80
52 Week Low
$7.48
No price data available for this timeframe.